Tim Cunningham

Director at Ortho Regenerative Technologies

Mr. Cunningham brings over 30 years of extensive finance and operations leadership experience in the biotechnology and software industries as a CFO with a demonstrated record of success in building start-up enterprises into industry leaders and scaling larger entities globally. His expertise includes financial & strategic planning, P&L management and execution, acquisitions & divestures, raising equity and debt and post-merger integration. Throughout his career, Mr. Cunningham has raised more than $500M in private and public equity as well as debt. Mr. Cunningham started his career in public accounting with KPMG in NYC and later with PWC in Boston. Prior to joining Danforth Advisors, he served as CFO at Organogenesis where he took the company public in 2018, raising $144M in equity and $100M in debt over his tenure. He built the teams, systems, processes and procedures leading to revenue growth from $98M in 2016 to a record $270M TTM in 2020 and the highest rating from each of the sell-side analysts Mr. Cunningham holds an MBA from Boston University, a BS in Accounting from Boston College and is a CPA in the states of New York & Florida.

Timeline

  • Director

    Current role